The present invention describes compositions comprising at least one compound chosen from hydroquinone and catechol, characterised in that it further comprises between 0.1 and 10,000 ppm of at least one compound chosen from 2-(alkoxy)phenol, 4-(alkoxy)phenol, 2-(alkyl)phenol, 4-(alkyl)phenol, (alkyl)catechol and (alkyl)hydroquinone. Another aspect of this invention concerns a method for preparing a composition comprising at least one compound chosen from hydroquinone and catechol according to the invention, characterised in that it comprises a step (a) of reacting the phenol with hydrogen peroxide in the presence of a catalyst, in a solvent comprising an alcohol.

There is disclosed an electrochemical deblocking solution for use on an electrode microarray. There is further disclosed a method for electrochemical synthesis on an electrode array using the electrochemical deblocking solution. The solution and method are for removing acid-labile protecting groups for synthesis of oligonucleotides, peptides, small molecules, or polymers on a microarray of electrodes while substantially improving isolation of deblocking to active electrodes. The method comprises applying a voltage or a current to at least one electrode of an array of electrodes. The array of electrodes is covered by the electrochemical deblocking solution.

There is disclosed an electrochemical deblocking solution for use on an electrode microarray. There is further disclosed a method for electrochemical synthesis on an electrode array using the electrochemical deblocking solution. The solution and method are for removing acid-labile protecting groups for synthesis of oligonucleotides, peptides, small molecules, or polymers on a microarray of electrodes while substantially improving isolation of deblocking to active electrodes. The method comprises applying a voltage or a current to at least one electrode of an array of electrodes. The array of electrodes is covered by the electrochemical deblocking solution.

The present invention relates to new lightly colored prills of hydroquinone. More particularly, the invention provides a new method for preparing said lightly colored prills of hydroquinone. The invention also relates to said prills of hydroquinone obtained by said new method.

The present invention relates to new lightly colored prills of hydroquinone. More particularly, the invention provides a new method for preparing said lightly colored prills of hydroquinone. The invention also relates to said prills of hydroquinone obtained by said new method.

In an LC system using an ODS column (15) and UV detector (17), a cannabis-derived sample is analyzed by gradient elution using a phosphoric acid aqueous solution and phosphoric-acid-containing methanol. A control unit (3) regulates the openings of solenoid valves in a mixer (12) so that the increase rate of the mixture ratio of the phosphoric-acid-containing methanol in a second part of the analysis period is higher than in a first part. By this operation, ten active ingredients (including Total THC, Total CBI) and CEN) contained in cannabis can be satisfactorily separated within an analysis time which is equal to or even shorter than approximately 30 minutes. Each ingredient separated by the column (15) is detected by the UV detector (17). An active ingredient identification processor (22) identifies the ten active ingredients based on the retention times of the peaks on a chromatogram created from the detection signals.

In an LC system using an ODS column (15) and UV detector (17), a cannabis-derived sample is analyzed by gradient elution using a phosphoric acid aqueous solution and phosphoric-acid-containing methanol. A control unit (3) regulates the openings of solenoid valves in a mixer (12) so that the increase rate of the mixture ratio of the phosphoric-acid-containing methanol in a second part of the analysis period is higher than in a first part. By this operation, ten active ingredients (including Total THC, Total CBI) and CEN) contained in cannabis can be satisfactorily separated within an analysis time which is equal to or even shorter than approximately 30 minutes. Each ingredient separated by the column (15) is detected by the UV detector (17). An active ingredient identification processor (22) identifies the ten active ingredients based on the retention times of the peaks on a chromatogram created from the detection signals.

The present invention relates to a co-crystalline form of efinaconazole and a pharmaceutically acceptable coformer forming a co-crystalline phase. The present invention also relates to a method for preparing the co-crystalline form. The co-crystallization product of efinaconazole according to the present invention meets all requirements for use as an active ingredient of a pharmaceutical composition and is highly stable to heat and other one or more other ingredients of the composition. Therefore, the co-crystallization product of efinaconazole is suitable for use in the preparation of pharmaceuticals. In addition, the method of the present invention enables the preparation of the co-crystallization product of efinaconazole in a simple and easy manner on a commercial scale.

A method and cell line for producing phytocannabinoids and phytocannabinoid analogues in yeast. The method applies, and the cell line includes, a yeast cell transformed with a polyketide synthase CDS and a cytosolic prenyltransferase CDS. The polyketide synthase enzyme catalyzes synthesis of olivetol or methyl-olivetol, and may include Cannabis sativa olivetolic acid synthase or Dictyostelium discoideum polyketide synthase (“DiPKS”). The yeast cell may be modified to include a phosphopantethienyl transferase for increased activity of DiPKS. The yeast cell may be modified to mitigate mitochondrial acetaldehyde catabolism for increasing malonyl-CoA available for synthesizing olivetol or methyl-olivetol. The prenyltransferase enzyme catalyzes synthesis of cannabigerol or a cannabigerol analogue, and may include an αββα cytosolic prenyltransferase enzyme from Streptomyces sp CL190. The yeast cell may be modified to mitigate depletion of geranyl pyrophosphate for increasing available geranyl pyrophosphate for prenylation.

The present disclosure provides a method for preparing resorcinol through micro-channel reaction. In the method, resorcinol is prepared through micro-channel reaction using m-aminophenol as a raw material, a diazo salt is synthesized at 0° C. or more, hydrolysis of the diazo salt is performed at 90° C. or less, and then reaction conditions are reduced; the reaction time is decreased from traditional 10 hours to less than 2 minutes, and therefore the reaction time is significantly shortened; the purity of a product is 75% or more, which is significantly improved. The method provided by the present disclosure has high heat exchange efficiency and high mass transfer rate; the efficiency of reaction is improved by hundreds of times; the reaction system is precisely controlled in the temperature and pressure, and safe and reliable in process, and meanwhile is capable of stably controlling hazard processes such as diazotization, so as to promote safe industry production, reduce energy consumption and greatly reduce industrial hazard waste emission and realize green ecology development.